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Introduction
T cells (TC) bearing Vγ9Vδ2+ γδ TC receptor (TCR), are a
subset of innate CD4-CD8- TC pro-inflammatory and
immunoregulatory TC recognizing non-peptidic phos-
phorylated mediator isopentenyl pyrophosphate (IPP) in
the mevalonate pathway. The role Vγ9Vδ2+ TC has never
been explored in JIA joints.
Patients and methods
Mononuclear cells (MC) isolated from synovial fluids
(SF) of 47 patients with monoarticular (M, n = 11), pau-
ciarticular (P, n = 19), extended (E, n = 5), polyarticular
(Po, n = 2), systemic (S, n = 4), psoriatic (Ps, n = 4),
enthesitis related (Sp, n = 2) JIA were dually stained with
monoclonal antibodies to CD3 and variable (V) regions
of the γδ TCR. Flow cytometry of fresh SFMC and follow-
ing in vitro 10 days stimulation with 0.5 mg/ml IPP plus
100 IU/ml interleukin-2 (IL-2) was performed.
Results
Vγ9Vδ2+TC constituted 6.8 ± 1.3%, 6.4 ± 0.9%, 4.6 ±
1.0%, 3.8 ± 3.6%, 5.6 ± 1.6%, 6.1 ± 0.1% and 1.3 ± 0.8%
of the SF CD3+cells in the M, P, E, Po, Ps, Sp and S JIA
types respectively, and were significantly higher in ANA+
(n = 19) than ANA- (n = 22) patients (7.8 ± 0.9% vs 4.1 ±
0.6% p < 0.004, Student T test). IPP and IL-2 activated
SFMC showed a greater expansion of Vγ9Vδ2+ TC of
ANA+ (n = 12) than ANA- (n = 18) patients (61.2 ± 17.1%
vs 31.7 ± 7.6%, p < 0.005) and of patients with M or P (n
= 11) relative to S, E or Po (n = 6) JIA (44.9 ± 10.9 vs 16.2
± 10.5 p < 0.02).
Conclusion
SF Vγ9Vδ2+ TC responses are stronger in M and P than in
E, Po, and S JIA and in ANA+ than – patients, suggesting
that a potent Vγ9Vδ2+ TC response may augment acute
inflammation while limiting progression to chronic and
destructive arthritis.
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